Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing investments by major market players in capsule manufacturing plants
4.2.2 Rising applications of softgel capsules in nutraceutical industries
4.2.3 Growth of the pharmaceutical industry provides opportunities for the softgel capsules market to grow worldwide
4.3 Restraints
4.3.1 High cost of vegetarian capsules
4.3.2 Fluctuating prices of raw materials
4.3.3 Rising demand for kosher- and halal-certified hard gelatin capsules
4.4 Opportunities
4.4.1 Non-gelatin softgel capsules
4.5 Technology Trends & Assessment
4.5.1 ?Smart capsule' is a potential new drug-delivery vehicle
4.5.2 Hydroxypropyl methylcellulose capsules (HPMC)
4.6 Macroeconomic indicators
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-sales Review
5.2 Porter's Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
6 Global Softgel Capsule Market, By Type
6.1 Introduction
6.1.1 Gelatin type
6.1.2 Non-animal type
6.1.3 Gelatin Capsule
6.1.4 Non- animal Capsule
7 Global Softgel Capsule Market, By Application
7.1 Introduction
7.1.1 Vitamins
7.1.2 Supplement
7.1.3 Nutrition
7.1.4 Vitamins
7.1.5 Supplement
7.1.6 Nutrition
8 Global Softgel Capsule Market, By Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.2 Latin America
8.3 Europe
8.4 Asia - Pacific
8.4.1 China
8.4.2 Japan
8.4.3 Rest of Asia-Pacific
8.5 Rest of the World
9 Competitive Landscape
9.1 Competitive Scenario
9.1.1 Introduction
9.2 Company Market Share Analysis
9.2.1 Introduction
9.3 Key Developments
10 Company Profile
10.1 Catalent, Inc
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products Offering
10.1.4 SWOT Analysis
10.1.5 Key Developments
10.1.6 Key strategy
10.2 Patheon (Part of Thermo Fisher Scientific)
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products Offering
10.2.4 SWOT Analysis
10.2.5 Key Developments
10.2.6 Key strategy
10.3 Capsugel (A part of Lonza)
10.3.1 Company Overview
10.3.2 Company Overview
10.3.3 Products Offering
10.3.4 SWOT Analysis
10.3.5 Key Developments
10.3.6 Key strategy
10.4 Captek Softgel International Inc.
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products Offering
10.4.4 SWOT Analysis
10.4.5 Key Developments
10.4.6 Key Strategy
10.5 EuroCaps Ltd. (Part of the DCC plc Group)
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products Offering
10.5.4 SWOT Analysis
10.5.5 Key Developments
10.5.6 Key Strategy
10.6 Amway
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products Offering
10.6.4 SWOT Analysis
10.6.5 Key Development
10.6.6 Key Strategy
10.7 Sirio Pharma Co. Ltd.
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products Offering
10.7.4 SWOT Analysis
10.7.5 Key Development
10.7.6 Key Strategy
10.8 Strides Pharma Science Limited
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products Offering
10.8.4 SWOT Analysis
10.8.5 Key Development
10.8.6 Key Strategy
10.9 International Vitamin Corporation
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products Offering
10.9.4 SWOT Analysis
10.9.5 Key Development
10.9.6 Key Strategy
10.1 Soft Gel Technologies, Inc.
10.10.1 Company Overview
10.10.2 Products Offering
10.10.3 SWOT Analysis
10.10.4 Key Development
10.10.5 Key Strategy
10.11 Weihai Baihe Biology Technological Co. Ltd.
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Products Offering
10.11.4 SWOT Analysis
10.11.5 Key Development
10.11.6 Key Strategy
10.12 China Shineway Pharmaceutical Group Limited
10.12.1 Company Overview
10.12.2 Financial Overview
10.12.3 Products Offering
10.12.4 SWOT Analysis
10.12.5 Key Development
10.12.6 Key Strategy
10.13 Yuwang Group
10.13.1 Company Overview
10.13.2 Financial Overview
10.13.3 Products Offering
10.13.4 SWOT Analysis
10.13.5 Key Development
10.13.6 Key Strategy
10.14 Guangdong Yichao Biological Co. Ltd.
10.14.1 Company Overview
10.14.2 Financial Overview
10.14.3 Products Offering
10.14.4 SWOT Analysis
10.14.5 Key Development
10.14.6 Key Strategy
11 Appendix
11.1 Discussion Blue Print